Howard V. Raff
Keine laufenden Positionen mehr
Profil
Dr. Howard V.
Raff was Chief Operating Officer at Aimmune Therapeutics, Inc.
Dr. Raff was previously employed as Adjunct Associate Professor by University of Washington, Chief Operating Officer by APT Pharmaceuticals, Inc., Head-West Coast Operations by Biologics Consulting Group, Inc., a Principal by Bristol-Myers Squibb Co., and a Principal by Genetic Systems Corp.
He received his undergraduate degree from the University of Illinois, a graduate degree from Washington State University, and a doctorate degree from Washington State University.
Ehemalige bekannte Positionen von Howard V. Raff
| Unternehmen | Position | Ende |
|---|---|---|
| AIMMUNE THERAPEUTICS, INC. | Geschäftsführer | 31.10.2015 |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
| Genetic Systems Corp. | Corporate Officer/Principal | - |
Biologics Consulting Group, Inc.
 Biologics Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Biologics Consulting Group, Inc. provides regulatory and product development advisory services for drugs and device products. It specializes in the preparation and review of CBER, CDER and CDRH regulatory applications, facility inspection, process validation packages, and electronic submissions. The company was founded by James G. Kenimer in 1993 and is headquartered in Alexandria, VA. | Corporate Officer/Principal | - |
Ausbildung von Howard V. Raff
| University of Illinois | Undergraduate Degree |
| Washington State University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Private Unternehmen | 4 |
|---|---|
APT Pharmaceuticals, Inc.
 APT Pharmaceuticals, Inc. BiotechnologyHealth Technology APT Pharmaceuticals, Inc. operated as a drug development company. The company was founded on December 15, 1999 and was headquartered in Burlingame, CA. | Health Technology |
Biologics Consulting Group, Inc.
Biologics Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Biologics Consulting Group, Inc. provides regulatory and product development advisory services for drugs and device products. It specializes in the preparation and review of CBER, CDER and CDRH regulatory applications, facility inspection, process validation packages, and electronic submissions. The company was founded by James G. Kenimer in 1993 and is headquartered in Alexandria, VA. | Commercial Services |
| Genetic Systems Corp. | |
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA. | Health Technology |
